| | | | | | | | | | | | | | | | |
| |
| Issue Date FY: 2025 ( Subtotal = $301,360 ) |
| 2025 | 2025 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2501ALPAAT | FY2025 (PAAT) Act Protection & Advocacy: Assistive Technology | 0 | 1 | ACL | 10/28/2024 | $15,162 |
| 2025 | 2025 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2501ALPADD | FY2025 (PADD) DD Act State Protection & Advocacy Systems | 0 | 1 | ACL | 10/28/2024 | $124,844 |
| 2025 | 2025 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | X98SM090373 | Protection & Advocacy for Individuals with Mntl Illness | 000 | 1 | SAMHSA | 11/6/2024 | $113,355 |
| 2025 | 2025 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2501ALPAVA | FY2025 (PAVA) HAVA Protection & Advocacy: Voting Access | 0 | 1 | ACL | 10/28/2024 | $31,297 |
| 2025 | 2025 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2501ALPATB | FY2025 (PATB) TBI Act Protection & Advocacy: Traumatic Brain Injury | 0 | 1 | ACL | 10/28/2024 | $16,702 |
| 2025 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R33NS123196 | Nanoparticles with Two-Stage Delivery of Tetrodotoxin for Prolonged Duration Local Anesthesia | 000 | 3 | NIH | 10/16/2024 | $3,447 |
| 2025 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | M0142451 | Behavioral Health Workforce Education and Training Program | 01 | 4 | HRSA | 10/30/2024 | $0 |
| 2025 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | T2639458 | Opioid-Impacted Family Support Program | 01 | 5 | HRSA | 10/1/2024 | $0 |
| 2025 | 2023 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R61NS123196 | Nanoparticles with Two-Stage Delivery of Tetrodotoxin for Prolonged Duration Local Anesthesia | 000 | 2 | NIH | 10/16/2024 | -$3,447 |
|
| Issue Date FY: 2024 ( Subtotal = $16,505,768 ) (Continued on the next page) |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R25GM142027 | The Health Sciences & Technology Academy – Alabama (HSTA-AL) | 001 | 4 | NIH | 5/7/2024 | $256,878 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R01DK125692 | Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis | 001 | 4 | NIH | 5/30/2024 | $18,496 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | X98SM089539 | Protection & Advocacy for Individuals with Mntl Illness | 002 | 1 | SAMHSA | 3/14/2024 | $38,298 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPAVA | FY2024 (PAVA) HAVA Protection & Advocacy: Voting Access | 3 | 1 | ACL | 5/22/2024 | $73,991 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPAVA | FY2024 (PAVA) HAVA Protection & Advocacy: Voting Access | 2 | 1 | ACL | 3/15/2024 | $18,886 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPAVA | FY2024 (PAVA) HAVA Protection & Advocacy: Voting Access | 0 | 1 | ACL | 10/27/2023 | $18,491 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | K01MH132545 | The influence of aerobic exercise on consolidation of fear extinction learning in PTSD | 000 | 3 | NIH | 2/21/2024 | $182,304 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPAVA | FY2024 (PAVA) HAVA Protection & Advocacy: Voting Access | 1 | 1 | ACL | 12/18/2023 | $29,675 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPADD | FY2024 (PADD) DD Act State Protection & Advocacy Systems | 3 | 1 | ACL | 5/22/2024 | $289,796 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPADD | FY2024 (PADD) DD Act State Protection & Advocacy Systems | 0 | 1 | ACL | 10/27/2023 | $72,420 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPADD | FY2024 (PADD) DD Act State Protection & Advocacy Systems | 2 | 1 | ACL | 3/15/2024 | $73,968 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPADD | FY2024 (PADD) DD Act State Protection & Advocacy Systems | 1 | 1 | ACL | 12/18/2023 | $116,229 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R03NS135559 | Phenotypic Analysis of SLC17A5 Neuromodulation in Salla Disease | 000 | 1 | NIH | 12/12/2023 | $149,000 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R33DC019073 | Improving Access and Affordability of Adult Hearing Healthcare: Effectiveness of Community-based Interventions in West Central and South Alabama | 000 | 4 | NIH | 12/29/2023 | $531,111 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01DK125692 | Targeting transient receptor potential channels to suppress proviral mitochondrial fission and mitophagy in order to mitigate CVB pancreatitis | 000 | 4 | NIH | 12/29/2023 | $277,435 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | X98SM089539 | Protection & Advocacy for Individuals with Mntl Illness | 000 | 1 | SAMHSA | 11/9/2023 | $65,656 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R34MH131599 | Stepped Transition in Education Program for Emerging Adults with Autism: Pilot Effectiveness Trial | 000 | 2 | NIH | 12/4/2023 | $201,150 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | X98SM089539 | Protection & Advocacy for Individuals with Mntl Illness | 001 | 1 | SAMHSA | 12/20/2023 | $105,324 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 301 ROSE ADMIN BLDG | TUSCALOOSA | AL | 35487-0001 | TUSCALOOSA | USA | R01MD013806 | Reducing Youth Violence and Racism/Discrimination: The Efficacy of Comprehensive Prevention Strategies (CPS) | 000 | 5 | NIH | 11/30/2023 | $425,368 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R33AG065619 | Enhancing Sleep Quality for Nursing Home Residents with Dementia: Pragmatic Trial | 001 | 3 | NIH | 5/13/2024 | $1,608,830 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R01GM144388 | Equipment Supplement - Cold triggered Local Anesthesia for Pain Management | 000 | 3 | NIH | 6/18/2024 | $311,932 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | M0142451 | Behavioral Health Workforce Education and Training Program | 00 | 4 | HRSA | 7/23/2024 | $500,000 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R01AI155908 | Engineering the next generation nanoparticle-cyclosporine A therapy in lupus | 000 | 5 | NIH | 8/9/2024 | $448,982 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPATB | FY2024 (PATB) TBI Act Protection & Advocacy: Traumatic Brain Injury | 2 | 1 | ACL | 3/15/2024 | $10,061 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPATB | FY2024 (PATB) TBI Act Protection & Advocacy: Traumatic Brain Injury | 0 | 1 | ACL | 10/27/2023 | $9,851 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPATB | FY2024 (PATB) TBI Act Protection & Advocacy: Traumatic Brain Injury | 1 | 1 | ACL | 12/18/2023 | $15,811 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 2401ALPATB | FY2024 (PATB) TBI Act Protection & Advocacy: Traumatic Brain Injury | 3 | 1 | ACL | 5/22/2024 | $39,420 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | 90YE0287 | Everyday Quality (EDQ): Building a Practical Toolkit for Continuous Quality Improvement in Family Child Care | 00 | 3 | ACF | 7/17/2024 | $400,000 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R03AI185593 | A Group B Streptococcus ordered CRISPR interference library to investigate host-pathogen interactions | 001 | 1 | NIH | 9/11/2024 | $7,450 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R03AI185593 | A Group B Streptococcus ordered CRISPR interference library to investigate host-pathogen interactions | 000 | 1 | NIH | 6/10/2024 | $67,050 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | D4033364 | Graduate Psychology Education Programs | 01 | 6 | HRSA | 8/16/2024 | $3,805 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | D4033364 | Graduate Psychology Education Programs | 01 | 6 | HRSA | 8/16/2024 | $11,413 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | D4033364 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $112,500 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | D4033364 | Graduate Psychology Education Programs | 00 | 6 | HRSA | 6/5/2024 | $337,500 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | NU58DP007590 | West Alabama Cardiovascular Health (WACH) Program | 00 | 2 | CDC | 8/21/2024 | $1,199,764 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R01DK128597 | Urolithin A nanoparticle therapy for acute kidney injury | 000 | 4 | NIH | 3/13/2024 | $290,837 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R01DK128597 | Urolithin A nanoparticle therapy for acute kidney injury | 001 | 4 | NIH | 5/8/2024 | $19,389 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | R15MH134225 | A Pilot Effectiveness Trial of an Adapted App-Based Mindfulness Intervention for Pre-Service Teachers | 000 | 1 | NIH | 3/15/2024 | $411,156 |
| 2024 | 2024 | UNIVERSITY OF ALABAMA | 801 UNIVERSITY BLVD | TUSCALOOSA | AL | 35401-2029 | TUSCALOOSA | USA | T3442131 | Primary Care Training and Enhancement-Community Prevention and Maternal Health | 00 | 4 | HRSA | 5/24/2024 | $316,963 |
|